Recombinant SARS-CoV-2 Spike RBD Protein, His tag (Animal-Free)

COVID-19 has become pandemic with higher morbidity and mortality rates after its start from Wuhan city of China. The infection by RNA virus, also known as SARS-CoV-2 or 2019-nCoV, from β class of corona viruses has been found to be responsible for COVID-19. Structural analysis and evidences have been indicated that interaction between a segment of receptor binding domain (RBD) from S protein of virus and human angiotensin-converting enzyme 2 (hACE2) is essential for cellular entry of virus. Inhibition of RBD-hACE2 interaction by different molecular scaffolds can be used as a preferred strategy for control of SARS-CoV-2 infection.

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Lyophilized Recombinant SARS-CoV-2 Spike RBD Protein, His tag (Animal-Free) should be stored desiccated below -20°C. Upon reconstitution, the protein should be stored at 4°C between 2-7 days and for future use below -20°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA) . Please prevent freeze-thaw cycles.

The recombinant SARS-CoV-2 (COVID-19) Spike RBD protein consists of 229 amino acids and predicts a molecular mass of 26.5 kD.The apparent molecular mass of the human CD33 is approximately 32-35 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Always centrifuge tubes before opening. It is recommended to reconstitute the lyophilized SARS-CoV-2 (COVID-19) S protein RBD protein not less than 100 µg/mL, which can then be further diluted to other aqueous solutions.

Amino acid sequence derived from SARS-CoV-2 (COVID-19) Spike RBD protein (YP_009724390.1, Arg319-Phe541) was expressed with a polyhistidine tag at the C-terminus.